Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Vasc Interv Radiol ; 28(3): 388-391, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28034701

ABSTRACT

PURPOSE: To evaluate relationship between Meniere disease (MD) and chronic cerebrospinal venous insufficiency (CCSVI) using ultrasound, magnetic resonance (MR) imaging, and venography and to evaluate the effectiveness of angioplasty of the internal jugular vein (IJV) and azygos vein (AV) in reducing symptoms of MD. MATERIALS AND METHODS: Patients with a confirmed diagnosis of MD unresponsive to standard treatment underwent duplex ultrasound and MR imaging to diagnose CCSVI. Healthy volunteers were also studied to evaluate CCSVI in asymptomatic subjects. Patients with CCSVI and MD underwent venography and percutaneous transluminal angioplasty (PTA) of IJV and AV. RESULTS: There were 182 patients with no clinical benefit from standard treatments evaluated. CCSVI was diagnosed in 175 (87.5%) patients with MD. Venography was performed in 69 patients to confirm the diagnosis of CCSVI. In 80% of these patients, PTA of the IJV and/or AV was effective for treating signs and symptoms of MD. In the healthy cohort, CCSVI was observed in only 12% of subjects. CONCLUSIONS: These results suggest a possible etiologic relationship between CCSVI and MD that warrants further investigation.


Subject(s)
Angioplasty, Balloon , Azygos Vein , Cerebrovascular Disorders/therapy , Jugular Veins , Meniere Disease/therapy , Spinal Cord/blood supply , Venous Insufficiency/therapy , Adult , Aged , Azygos Vein/diagnostic imaging , Case-Control Studies , Cerebrovascular Disorders/diagnostic imaging , Cerebrovascular Disorders/epidemiology , Chronic Disease , Female , Humans , Italy/epidemiology , Jugular Veins/diagnostic imaging , Magnetic Resonance Angiography , Male , Meniere Disease/diagnostic imaging , Meniere Disease/epidemiology , Middle Aged , Phlebography/methods , Prevalence , Risk Factors , Time Factors , Treatment Outcome , Ultrasonography, Doppler, Duplex , Venous Insufficiency/diagnostic imaging , Venous Insufficiency/epidemiology
2.
Acta Otolaryngol ; 137(5): 460-463, 2017 May.
Article in English | MEDLINE | ID: mdl-27846752

ABSTRACT

CONCLUSION: The present study confirms a correlation between chronic cerebrospinal venous insufficiency (CCSVI) diagnosis and Ménière's disease (MD). CCSVI could be considered a new ultrasound vascular pattern of the cerebrospinal venous system in patients affected by definite MD. Conversely, the present results showed that CCSVI cannot be considered a pathogenic mechanism for idiopathic sudden sensorineural hearing loss (ISSNHL). OBJECTIVES: The aim of this study is to investigate the correlation between CCSVI and MD and to evaluate if CCSVI can be considered a risk factor also for ISSNHL. Moreover, this study seeks to establish if, even with a different timing of onset and natural history, MD and ISSNHL may share a common pathogenic mechanism. METHOD: One hundred and eighty-two patients affected by definite MD, 60 patients affected by ISSNHL, and 100 healthy control patients were enrolled in this study. All subjects underwent an echo-color Doppler (ECD) of the cerebrospinal venous flow. RESULTS: One hundred and fifty-two patients affected by definite MD (83,5%) and 13 patients affected by ISSNHL (21.6%) were positive for CCSVI at the ECD examination of the cerebrospinal venous flow. The healthy control group consisted of 100 subjects and only 21 (21%) showed positivity for CCSVI.


Subject(s)
Cerebrovascular Circulation , Hearing Loss, Sensorineural/etiology , Hearing Loss, Sudden/etiology , Meniere Disease/etiology , Venous Insufficiency/complications , Adult , Case-Control Studies , Female , Humans , Male , Meniere Disease/diagnostic imaging , Middle Aged , Ultrasonography, Doppler, Color
3.
Acta Otolaryngol ; 135(10): 969-73, 2015.
Article in English | MEDLINE | ID: mdl-26204857

ABSTRACT

CONCLUSIONS: The present study shows that AGE, DELAY, and PTA_PRE may be considered factors influencing therapeutic success in intra-tympanic steroid therapy. OBJECTIVE: The aim of the study is to evaluate the relationship between the therapeutic success of intra-tympanic prednisolone therapy and age, in patients affected by idiopathic sudden sensorineural hearing loss (ISSNHL), considering the influence of factors such as delay, gender, and pure tone average (PTA) pre-therapy. METHOD: This retrospective study involved 402 consecutive patients, affected by unilateral ISSNHL between January 2009 and January 2014. Patients were divided into two groups based on age: group one with 94 patients aged over 65 years and group two with all 402 patients enrolled in the study, including those over 65. RESULTS: PTA recorded before the beginning of the therapy (PTA_PRE) in group one was worse than for group two. In both groups the therapy was significantly effective in improving hearing thresholds, even if PTA_PRE was significant and negatively correlated with success rate. This effect disappeared within the population over 65. On average, each day of DELAY from the onset of hearing loss to the beginning of therapy cuts almost 2% of the possibility to recover. AGE was negative and significant when specified continuously for group two.


Subject(s)
Hearing Loss, Sensorineural/drug therapy , Hearing Loss, Sudden/drug therapy , Prednisolone/administration & dosage , Adolescent , Adult , Aged , Aged, 80 and over , Audiometry, Pure-Tone , Child , Female , Follow-Up Studies , Glucocorticoids/administration & dosage , Hearing Loss, Sensorineural/physiopathology , Hearing Loss, Sudden/physiopathology , Humans , Injections, Intralesional , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Tympanic Membrane , Young Adult
4.
Am J Otolaryngol ; 34(6): 718-9, 2013.
Article in English | MEDLINE | ID: mdl-23948794

ABSTRACT

Idiopathic causes of retroauricular pain are rarely seen in clinical practice. We present a 9-year-old child who suffered from atypical retroauricular pain resistant to conventional treatment. After excluding any other cause of retroauricular pain, a nerve block was performed with a 0.3 ml lidocaine 1% injection into the trigger point. We believe that this case report is important because in the literature there are no similar cases described in children.


Subject(s)
Earache/therapy , Nerve Block , Amines/therapeutic use , Analgesics/therapeutic use , Anesthetics, Local/administration & dosage , Carbamazepine/therapeutic use , Child , Cyclohexanecarboxylic Acids/therapeutic use , Gabapentin , Humans , Injections , Lidocaine/administration & dosage , Male , Trigger Points , gamma-Aminobutyric Acid/therapeutic use
5.
Acta Otolaryngol ; 133(9): 900-4, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23692396

ABSTRACT

CONCLUSION: The results demonstrate the stability of the efficacy over time of the intratympanic prednisolone protocol and they suggest that the spontaneous recovery does not significantly influence the long-term evaluation of intratympanic therapy. A 10-day follow-up after 3 days of intratympanic prednisolone administration can be considered a sufficient period to evaluate the effectiveness of the undertaken therapy. OBJECTIVE: To assess the stability of the efficacy over time of intratympanic steroid therapy for patients with idiopathic sudden sensorineural hearing loss. METHODS: A total of 122 patients received an intratympanic steroid injection of prednisolone daily for 3 days. Audiograms were performed before therapy and at 10 days and 1 year after therapy. Successful recovery was defined as complete and partial recovery using Siegel's criteria and complete and marked recovery following Furuhashi's criteria. RESULTS: The comparison of audiometric data at study entry, at 10 days, and at 1 year after the treatment showed a statistically significant improvement of the mean pure tone audiometry. The evaluation of the hearing outcomes demonstrated a statistically significant improvement, with similar success rates when evaluated 10 days and 1 year after the treatment. Comparing the hearing outcomes at 1 year with the results at 10 days, no significant difference was detected between these two time points.


Subject(s)
Glucocorticoids/administration & dosage , Hearing Loss, Sensorineural/drug therapy , Prednisolone/administration & dosage , Adult , Aged , Female , Follow-Up Studies , Hearing Tests , Humans , Injections , Long-Term Care , Male , Middle Aged , Treatment Outcome , Tympanic Membrane
SELECTION OF CITATIONS
SEARCH DETAIL
...